Skip to main content
German Center for Infection Research
  • Research
    • Back
    • Bridging Topics
    • Research Areas
    • Infrastructures
    • Working Groups
    • Projects
    • African Partner Institutions
    • Clinical Trials
    • Publications
  • Translation
    • Back
    • Developing Medication
    • Successful Translation
    • Collaborations
    • German Centers for Health Research
  • DZIF Academy
  • Newsroom
    • Back
    • News
    • Media Centre
    • Press Office
    • Events
    • Jobs
  • About us
    • Back
    • Portrait
    • DZIF Structure and Bodies
    • Partner Sites
    • Executive Board
    • DZIF Patient Advisory Board
    • Staff
    • Main Office
    • Donations
  • De
  • |
  • En

Search

Breadcrumb

  1. Home
  2. Search
Masernimpfvirus als Vektor

Bitte verwenden Sie dieses Bild nur in Zusammenhang mit der Pressemitteilung.

© PEI

© PEI
Dec 1 2020

Measles virus as vector for a COVID-19 vaccine.

As part of the research activities within the German Center for Infection Research (DZIF), scientists of the Paul-Ehrlich-Institut studied specific vaccine candidates against COVID-19. They are based

Nov 2020

A highly immunogenic and effective measles virus-based Th1-biased COVID-19 vaccine

Autoren
Hörner C et al.
Aug 2020
Front Immunol

Combating COVID-19: MVA Vector Vaccines Applied to the Respiratory Tract as Promising Approach Toward Protective Immunity in the Lung

Autoren
Förster R
Fleige H
Sutter G
Aug 2020
Viruses

Ebola Virus Disease Survivors Show More Efficient Antibody Immunity than Vaccinees Despite Similar Levels of Circulating Immunoglobulins

Autoren
Koch T et al.
Jul 2020
Vaccines

Impact of Helminth Infections during Pregnancy on Vaccine Immunogenicity in Gabonese Infants

Autoren
Flügge J et al.
Jul 2020
J Infect Dis

Randomized, Blinded, Dose-Ranging Trial of an Ebola Virus Glycoprotein Nanoparticle Vaccine With Matrix-M Adjuvant in Healthy Adults

Autoren
Fries L et al.
Corona-Impfstoffe im Test

Please use this photo only in connection to the press release.

© Bill Oxford/ iStock

© Bill Oxford/ iStock
Nov 20 2020

COVID-19: Participation in vaccine trials

Willingness to volunteer for COVID-19 vaccine trials is high. But what trials are underway and who can be contacted for further information? To answer these questions and to match interested

Jun 2020
Vaccine

Effect of immune regulatory pathways after immunization with GMZ2 malaria vaccine candidate in healthy lifelong malaria-exposed adults

Autoren
Nouatin O et al.
Apr 2020
Lancet Infect Dis

Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial

Autoren
Folegatti PM et al.
May 2020
Biotechnol J

Epitopes of Naturally Acquired and Vaccine-induced Anti-Ebola Virus Glycoprotein Antibodies in Single Amino Acid Resolution

Autoren
Heidepriem J et al.

Pagination

Previous page ‹‹
Seite 25 Seite 26 Seite 27 Seite 28 Current page 29 Seite 30 Seite 31 Seite 32 Seite 33
Next page ››

Sitemap

  • Research
  • Translation
  • DZIF Academy
  • Newsroom
  • About us

At one click

  • Jobs
  • Media Centre
  • Press releases
  • Press contact
  • Glossary
  • Donations

Newsletter Subscription

Contact

Main Office of the DZIF e. V.
Inhoffenstraße 7
38124 Braunschweig
​

E-Mail Send mail

Fußbereichsmenü

  • DZIF Portal (internal)
  • Whistleblower system
  • Imprint
  • Privacy policy
  • Log in
  • Manage cookie consent
German Centers for Health Research
Supported by the Federal Ministry of Research, Technology and Space and the participating federal states